Microsoft March 2026 Patch Tuesday fixes 2 zero-days, 79 flaws

Today is Microsoft's March 2026 Patch Tuesday with security updates for 79 flaws, including 2 publicly disclosed zero-day ...
Yahoo Finance

The Bull Case For Recursion Pharmaceuticals (RXRX) Could Change Following Nvidia’s Exit And ARK’s Big Buy-In

Nvidia disclosed in recent regulatory filings that it had fully exited its roughly two‑year, 7.71 million‑share investment in Recursion Pharmaceuticals, while Cathie Wood’s ARK Invest simultaneously ...
Yahoo Finance

Recursion Pharmaceuticals to Report Q4 Earnings: What's in the Cards?

Recursion Pharmaceuticals RXRX, a TechBio company that decodes biology and chemistry to industrialize drug discovery, is expected to report fourth-quarter 2025 results soon. The Zacks Consensus ...
Mena FN

Recursion Reports Fourth Quarter And Full Year 2025 Financial Results And Provides Business Update

Delivered first clinical validation of the Recursion full stack AI Operating System in FAP, demonstrating translation from AI-driven biological insight to meaningful patient outcomes; multiple ...
Investing

Earnings call transcript: Recursion Pharmaceuticals beats Q4 2025 forecasts

Recursion Pharmaceuticals reported its fourth-quarter 2025 earnings, showcasing a significant beat on both earnings and revenue forecasts. The company reported an EPS of -$0.21, surpassing the ...
The Motley Fool

Cathie Wood Goes Bargain Hunting: 3 Stocks She Just Bought

Cathie Wood's Ark Invest bought shares in Figma, CoreWeave, and Recursion Pharmaceuticals on Friday. Figma stock has fallen 30% this year, but it's been rising in recent days with a strong quarterly ...